Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kaustav Bera to Prognosis

This is a "connection" page, showing publications Kaustav Bera has written about Prognosis.

 
Connection Strength
 
 
 
0.492
 
  1. Bera K, Velcheti V, Madabhushi A. Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:1008-1018.
    View in: PubMed
    Score: 0.082
  2. Ismail M, Prasanna P, Bera K, Statsevych V, Hill V, Singh G, Partovi S, Beig N, McGarry S, Laviolette P, Ahluwalia M, Madabhushi A, Tiwari P. Radiomic Deformation and Textural Heterogeneity (R-DepTH) Descriptor to Characterize Tumor Field Effect: Application to Survival Prediction in Glioblastoma. IEEE Trans Med Imaging. 2022 07; 41(7):1764-1777.
    View in: PubMed
    Score: 0.027
  3. Corredor G, Toro P, Koyuncu C, Lu C, Buzzy C, Bera K, Fu P, Mehrad M, Ely KA, Mokhtari M, Yang K, Chute D, Adelstein DJ, Thompson LDR, Bishop JA, Faraji F, Thorstad W, Castro P, Sandulache V, Koyfman SA, Lewis JS, Madabhushi A. An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):609-617.
    View in: PubMed
    Score: 0.027
  4. Wilde DC, Castro PD, Bera K, Lai S, Madabhushi A, Corredor G, Koyuncu C, Lewis JS, Lu C, Frederick MJ, Frederick AM, Haugen AE, Zevallos JP, Sturgis EM, Shi J, Huang AT, Hernandez DJ, Skinner HD, Kemnade JO, Yu W, Sikora AG, Sandulache VC. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
    View in: PubMed
    Score: 0.026
  5. Azarianpour S, Corredor G, Bera K, Leo P, Fu P, Toro P, Joehlin-Price A, Mokhtari M, Mahdi H, Madabhushi A. Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities. J Immunother Cancer. 2022 02; 10(2).
    View in: PubMed
    Score: 0.026
  6. Leo P, Chandramouli S, Farr? X, Elliott R, Janowczyk A, Bera K, Fu P, Janaki N, El-Fahmawi A, Shahait M, Kim J, Lee D, Yamoah K, Rebbeck TR, Khani F, Robinson BD, Shih NNC, Feldman M, Gupta S, McKenney J, Lal P, Madabhushi A. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2. Eur Urol Focus. 2021 Jul; 7(4):722-732.
    View in: PubMed
    Score: 0.025
  7. Khorrami M, Bera K, Thawani R, Rajiah P, Gupta A, Fu P, Linden P, Pennell N, Jacono F, Gilkeson RC, Velcheti V, Madabhushi A. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans. Eur J Cancer. 2021 05; 148:146-158.
    View in: PubMed
    Score: 0.025
  8. Beig N, Singh S, Bera K, Prasanna P, Singh G, Chen J, Saeed Bamashmos A, Barnett A, Hunter K, Statsevych V, Hill VB, Varadan V, Madabhushi A, Ahluwalia MS, Tiwari P. Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma. Neuro Oncol. 2021 02 25; 23(2):251-263.
    View in: PubMed
    Score: 0.025
  9. Liu JTC, Glaser AK, Bera K, True LD, Reder NP, Eliceiri KW, Madabhushi A. Harnessing non-destructive 3D pathology. Nat Biomed Eng. 2021 03; 5(3):203-218.
    View in: PubMed
    Score: 0.025
  10. Lu C, Koyuncu C, Corredor G, Prasanna P, Leo P, Wang X, Janowczyk A, Bera K, Lewis J, Velcheti V, Madabhushi A. Feature-driven local cell graph (FLocK): New computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers. Med Image Anal. 2021 02; 68:101903.
    View in: PubMed
    Score: 0.024
  11. Lu C, Bera K, Wang X, Prasanna P, Xu J, Janowczyk A, Beig N, Yang M, Fu P, Lewis J, Choi H, Schmid RA, Berezowska S, Schalper K, Rimm D, Velcheti V, Madabhushi A. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study. Lancet Digit Health. 2020 11; 2(11):e594-e606.
    View in: PubMed
    Score: 0.024
  12. Khorrami M, Bera K, Leo P, Vaidya P, Patil P, Thawani R, Velu P, Rajiah P, Alilou M, Choi H, Feldman MD, Gilkeson RC, Linden P, Fu P, Pass H, Velcheti V, Madabhushi A. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study. Lung Cancer. 2020 04; 142:90-97.
    View in: PubMed
    Score: 0.023
  13. Beig N, Bera K, Prasanna P, Antunes J, Correa R, Singh S, Saeed Bamashmos A, Ismail M, Braman N, Verma R, Hill VB, Statsevych V, Ahluwalia MS, Varadan V, Madabhushi A, Tiwari P. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma. Clin Cancer Res. 2020 04 15; 26(8):1866-1876.
    View in: PubMed
    Score: 0.023
  14. Vaidya P, Bera K, Gupta A, Wang X, Corredor G, Fu P, Beig N, Prasanna P, Patil PD, Velu PD, Rajiah P, Gilkeson R, Feldman MD, Choi H, Velcheti V, Madabhushi A. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction. Lancet Digit Health. 2020 03; 2(3):e116-e128.
    View in: PubMed
    Score: 0.023
  15. Khorrami M, Prasanna P, Gupta A, Patil P, Velu PD, Thawani R, Corredor G, Alilou M, Bera K, Fu P, Feldman M, Velcheti V, Madabhushi A. Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer. Cancer Immunol Res. 2020 01; 8(1):108-119.
    View in: PubMed
    Score: 0.023
  16. Li H, Whitney J, Bera K, Gilmore H, Thorat MA, Badve S, Madabhushi A. Quantitative nuclear histomorphometric features are predictive of Oncotype DX risk categories in ductal carcinoma in situ: preliminary findings. Breast Cancer Res. 2019 10 17; 21(1):114.
    View in: PubMed
    Score: 0.022
  17. Khorrami M, Jain P, Bera K, Alilou M, Thawani R, Patil P, Ahmad U, Murthy S, Stephans K, Fu P, Velcheti V, Madabhushi A. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features. Lung Cancer. 2019 09; 135:1-9.
    View in: PubMed
    Score: 0.022
  18. Beig N, Patel J, Prasanna P, Hill V, Gupta A, Correa R, Bera K, Singh S, Partovi S, Varadan V, Ahluwalia M, Madabhushi A, Tiwari P. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma. Sci Rep. 2018 01 08; 8(1):7.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)